Ozan Pamir insider trades
Open-market stock purchases and sales by Ozan Pamir, Chief Financial Officer at Niagen Bioscience, Inc, from SEC Form 4 filings since Feb 26, 2021.
Track record: 0% of 2 scored buys are up 5% or more since purchase, averaging -49%.